Investigators at the Northwestern University Feinberg School of Medicine have just presented new data that shows when a key protein responsible for leukemia—dubbed mixed-lineage leukemia 1 (MLL1)—is stabilized; it slows the progression of the disease. This is the second successful therapy that slowed the progression of pediatric leukemia in mice, according to three studies published […]
The post “Super Drug” for Pediatric Leukemia Could Become Reality appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: “Super Drug” for Pediatric Leukemia Could Become Reality